These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2297699)

  • 1. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.
    St Clair WH; Billings PC; Carew JA; Keller-McGandy C; Newberne P; Kennedy AR
    Cancer Res; 1990 Feb; 50(3):580-6. PubMed ID: 2297699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis.
    Kennedy AR; Billings PC; Wan XS; Newberne PM
    Nutr Cancer; 2002; 43(2):174-86. PubMed ID: 12588698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
    Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine.
    Billings PC; Newberne PM; Kennedy AR
    Carcinogenesis; 1990 Jul; 11(7):1083-6. PubMed ID: 2372868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of carcinogenesis by protease inhibitors.
    Kennedy AR
    Cancer Res; 1994 Apr; 54(7 Suppl):1999s-2005s. PubMed ID: 8137328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
    Kennedy AR; Beazer-Barclay Y; Kinzler KW; Newberne PM
    Cancer Res; 1996 Feb; 56(4):679-82. PubMed ID: 8630994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
    Chen YW; Huang SC; Lin-Shiau SY; Lin JK
    Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H; Kennedy AR; Witschi H; Shen WC
    J Drug Target; 1993; 1(1):41-9. PubMed ID: 8069543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against metastasis of radiation-induced thymic lymphosarcoma and weight loss in C57Bl/6NCr1BR mice by an autoclave-resistant factor present in soybeans.
    Evans SM; Van Winkle T; Szuhaj B; Michel KE; Kennedy AR
    Radiat Res; 1992 Nov; 132(2):259-62. PubMed ID: 1438709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
    Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
    Billings PC; St Clair W; Owen AJ; Kennedy AR
    Cancer Res; 1988 Apr; 48(7):1798-802. PubMed ID: 3280120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice.
    Suzuki K; Yano T; Sadzuka Y; Sugiyama T; Seki T; Asano R
    Oncol Rep; 2005 Jun; 13(6):1247-50. PubMed ID: 15870950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of oral carcinogenesis by a protease inhibitor.
    Messadi DV; Billings P; Shklar G; Kennedy AR
    J Natl Cancer Inst; 1986 Mar; 76(3):447-52. PubMed ID: 3081747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB; Liu SP; Broderick GA; Wein AJ; Kennedy AR; Levin RM
    Neurourol Urodyn; 2003; 22(1):54-7. PubMed ID: 12478602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB; Kennedy AR; Wan XS; Atiba J; McLaren CE; Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):43-7. PubMed ID: 10667462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective radioprotection of normal tissues by Bowman-birk proteinase inhibitor (BBI) in mice.
    Dittmann K; Toulany M; Classen J; Heinrich V; Milas L; Rodemann HP
    Strahlenther Onkol; 2005 Mar; 181(3):191-6. PubMed ID: 15756524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
    Ware JH; Wan XS; Kennedy AR
    Nutr Cancer; 1999; 33(2):174-7. PubMed ID: 10368813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor induction in mice administered neonatally with 1,2-dimethylhydrazine.
    Fujii K; Komano H
    Sci Rep Res Inst Tohoku Univ Med; 1989 Dec; 36(1-4):46-50. PubMed ID: 2640067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans.
    Maki PA; Paterson Y; Kennedy AR
    Nutr Cancer; 1994; 22(2):185-93. PubMed ID: 14502847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.